Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin for plantar lesions in localized epidermolysis bullosa simplex
2017-002332-16Phase 2Terminated
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Aug 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of neuronox in epidermolysis bullosa simplex (EBS), sponsored by Centre hospitalier universitaire de Toulouse. Started Aug 2017; status: terminated.
02
Drugs
neuronox
03
Conditions
epidermolysis bullosa simplex (EBS)
Beyond the preview
Go deeper on 2017-002332-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002332-16.